A Novel Bispecific Fusion Protein Targeting C3b/C4b and VEGF in Patients With nAMD: A Randomized, Open-Label, Phase 1b Study-Reference-Cited by-同舟云学术

A Novel Bispecific Fusion Protein Targeting C3b/C4b and VEGF in Patients With nAMD: A Randomized, Open-Label, Phase 1b Study

Published:2023-04 Issue: Volume:248 Page:8-15
ISSN:0002-9394
Container-title:American Journal of Ophthalmology
language:en
Short-container-title:American Journal of Ophthalmology

Author:

Jia Huixun,Li Tong^ORCID,Sun Junran,Gong Yuanyuan,Liu Haiyun,Wang Hong,Chen Jieqiong,Liu Wenjia,Lu Shujie,Feng Liqi,Wan Qiuchen,Qian Lei,Wang Fenghua,Liu Xiaoling,Sun Xiaodong^ORCID

Funder

Innovent Biologics

Publisher

Elsevier BV

Subject

Ophthalmology

Reference26 articles.

1. Anti-vascular endothelial growth factor for neovascular age-related macular degeneration;Solomon;Cochrane Database Syst Rev,2014

2. Visual acuity outcomes and anti-vascular endothelial growth factor therapy intensity in neovascular age-related macular degeneration patients: a real-world analysis of 49 485 eyes;Ciulla;Ophthalmol Retina,2020

3. Incomplete response to anti-VEGF therapy in neovascular AMD: exploring disease mechanisms and therapeutic opportunities;Mettu;Prog Retin Eye Res,2021

4. Molecular pathogenesis of retinal and choroidal vascular diseases;Campochiaro;Prog Retin Eye Res,2015

5. A large genome-wide association study of age-related macular degeneration highlights contributions of rare and common variants;Fritsche;Nat Genet,2016

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Role of inflammation in diabetic macular edema and neovascular age-related macular degeneration;Survey of Ophthalmology;2024-11

2. Efficacy and safety of efdamrofusp alfa versus aflibercept in participants with neovascular age-related macular degeneration: a randomized, double-masked, active-controlled, non-inferiority, phase 2 trial;Ophthalmology Retina;2024-08

3. Identification of systemic biomarkers and potential drug targets for age-related macular degeneration;Frontiers in Aging Neuroscience;2024-02-01

4. Crosstalk Between Microglia and Müller Glia in the Age-Related Macular Degeneration: Role and Therapeutic Value of Neuroinflammation;aging and disease;2024

5. Therapeutic targeting of the complement system in ocular disease;Drug Discovery Today;2023-11